Provided by Tiger Trade Technology Pte. Ltd.

Abeona Therapeutics

5.13
+0.23004.69%
Post-market: 5.10-0.0300-0.58%19:42 EST
Volume:878.70K
Turnover:4.48M
Market Cap:278.00M
PE:4.24
High:5.16
Open:4.99
Low:4.93
Close:4.90
52wk High:7.54
52wk Low:3.93
Shares:54.19M
Float Shares:38.26M
Volume Ratio:0.92
T/O Rate:2.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.21
EPS(LYR):-1.5527
ROE:75.90%
ROA:-29.57%
PB:1.62
PE(LYR):-3.30

Loading ...

Top Abeona Therapeutics Insider Quietly Executes Notable Stock Sale

TIPRANKS
·
Feb 05

Vogo SA Appoints New Board Members Following ABEO Acquisition

Reuters
·
Feb 04

Multiple Abeona Therapeutics Directors Quietly Unload Significant Blocks of Stock

TIPRANKS
·
Feb 03

Insider-Favored Growth Companies To Watch February 2026

Simply Wall St.
·
Feb 03

Top Abeona Therapeutics Executive Makes Notable Move With Fresh Stock Sale

TIPRANKS
·
Jan 27

Abeona Therapeutics Files Initial Beneficial Ownership Statement for Chief Commercial Officer Madhav Vasanthavada

Reuters
·
Jan 27

Abeona Therapeutics Director Makes Notable Insider Move With Fresh Stock Sale

TIPRANKS
·
Jan 22

Abeona Therapeutics Director Mark Alvino Reports Disposal of Common Shares

Reuters
·
Jan 22

3 Insider-Owned Growth Stocks For Your Watchlist

Simply Wall St.
·
Jan 02

BRIEF-Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Dec 31, 2025

Abeona Therapeutics Grants Restricted Stock Awards to New Employees

Reuters
·
Dec 31, 2025

Abeona Therapeutics CEO Vishwas Seshadri Reports Sale of Common Shares

Reuters
·
Dec 30, 2025

ABEO Secures 90.84% Stake in VOGO After Reopened Offer

Reuters
·
Dec 23, 2025

Abeona Therapeutics Appoints Mohamad Tabrizi as Chief Business Officer

Reuters
·
Dec 15, 2025

Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer

THOMSON REUTERS
·
Dec 15, 2025

Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas

GlobeNewswire
·
Dec 11, 2025

Abeona Therapeutics Treats First Patient With FDA-Approved ZEVASKYN Gene Therapy

Reuters
·
Dec 08, 2025

Abeona Therapeutics® Announces First Patient Treatment With Zevaskyn® Gene Therapy

THOMSON REUTERS
·
Dec 08, 2025

ABEO Acquires 86.43% Stake in VOGO

Reuters
·
Dec 04, 2025

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Dec 01, 2025